Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
8.09
-0.47 (-5.49%)
Mar 28, 2025, 4:00 PM EDT - Market closed
Teladoc Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 2,570 | 2,602 | 2,407 | 2,033 | 1,094 | Upgrade
|
| Revenue Growth (YoY) | -1.26% | 8.13% | 18.41% | 85.81% | 97.71% | Upgrade
|
| Cost of Revenue | 751.27 | 760.03 | 743.99 | 650.26 | 390.83 | Upgrade
|
| Gross Profit | 1,818 | 1,842 | 1,663 | 1,382 | 703.13 | Upgrade
|
| Selling, General & Admin | 1,346 | 1,367 | 1,301 | 1,105 | 886.88 | Upgrade
|
| Research & Development | 307.27 | 348.52 | 333.63 | 311.88 | 164.94 | Upgrade
|
| Operating Expenses | 2,027 | 2,053 | 1,890 | 1,621 | 1,121 | Upgrade
|
| Operating Income | -208.79 | -210.5 | -227.36 | -238.99 | -418.19 | Upgrade
|
| Interest Expense | -23.8 | -22.28 | -21.94 | -81.14 | -59.95 | Upgrade
|
| Interest & Investment Income | 57.07 | 46.78 | 12.67 | 0.78 | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | -0.81 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -6.04 | 4.45 | -0.86 | - | -0.55 | Upgrade
|
| EBT Excluding Unusual Items | -181.56 | -181.56 | -237.49 | -320.17 | -478.68 | Upgrade
|
| Merger & Restructuring Charges | -22.1 | -38.05 | -23.04 | -26.64 | -88.24 | Upgrade
|
| Impairment of Goodwill | -790 | - | -13,403 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 5.9 | - | Upgrade
|
| Asset Writedown | - | - | -0.01 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | -43.75 | -9.08 | Upgrade
|
| Pretax Income | -993.65 | -219.61 | -13,663 | -384.66 | -575.99 | Upgrade
|
| Income Tax Expense | 7.59 | 0.76 | -3.81 | 44.14 | -90.86 | Upgrade
|
| Net Income | -1,001 | -220.37 | -13,660 | -428.79 | -485.14 | Upgrade
|
| Net Income to Common | -1,001 | -220.37 | -13,660 | -428.79 | -485.14 | Upgrade
|
| Shares Outstanding (Basic) | 171 | 165 | 161 | 157 | 91 | Upgrade
|
| Shares Outstanding (Diluted) | 171 | 165 | 161 | 157 | 91 | Upgrade
|
| Shares Change (YoY) | 3.64% | 1.93% | 2.88% | 73.40% | 25.98% | Upgrade
|
| EPS (Basic) | -5.87 | -1.34 | -84.60 | -2.73 | -5.36 | Upgrade
|
| EPS (Diluted) | -5.87 | -1.34 | -84.60 | -2.73 | -5.36 | Upgrade
|
| Free Cash Flow | 282.89 | 338.56 | 172.81 | 185.46 | -57.54 | Upgrade
|
| Free Cash Flow Per Share | 1.66 | 2.06 | 1.07 | 1.18 | -0.64 | Upgrade
|
| Gross Margin | 70.76% | 70.80% | 69.09% | 68.01% | 64.27% | Upgrade
|
| Operating Margin | -8.13% | -8.09% | -9.45% | -11.76% | -38.23% | Upgrade
|
| Profit Margin | -38.96% | -8.47% | -567.53% | -21.09% | -44.35% | Upgrade
|
| Free Cash Flow Margin | 11.01% | 13.01% | 7.18% | 9.12% | -5.26% | Upgrade
|
| EBITDA | 31.72 | 43.61 | -17.43 | -31.42 | -354.49 | Upgrade
|
| EBITDA Margin | 1.23% | 1.68% | -0.72% | -1.55% | -32.40% | Upgrade
|
| D&A For EBITDA | 240.51 | 254.11 | 209.93 | 207.57 | 63.69 | Upgrade
|
| EBIT | -208.79 | -210.5 | -227.36 | -238.99 | -418.19 | Upgrade
|
| EBIT Margin | -8.13% | -8.09% | -9.45% | -11.76% | -38.23% | Upgrade
|
| Advertising Expenses | 693.21 | 673.55 | 609.45 | 397.77 | 199.15 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.